SUSPENDED

Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer

Talk to us

Conditions

Head and Neck Squamous Cell CarcinomaImaging device

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to assess the safety and evaluate the potential of the Multispectral Optoacoustic Tomography (MSOT) device to more precisely identify and assess the neck lymph nodes which might be affected in patients with metastatic head and neck squamous cell carcinomas.

Official Title

Multispectral Optoacoustic Tomography for the Detection of Extranodal Extension and Radiation Induced Fibrosis in Head and Neck Squamous Cell Cancer

Quick Facts

Study Start:2026-05
Study Completion:2027-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:SUSPENDED

Study ID

NCT06477003

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Clinically confirmed node positive head and neck squamous cell cancer
  2. * Written informed consent signed and dated by the patient prior to the performance of the MSOT
  3. * At least 18 years-of-age at the time of signature of the informed consent form (ICF)
  4. * Patients planned for curative intent therapy
  5. * Patient available for the study duration
  6. * Patients of childbearing potential must have a negative pregnancy test prior to the study entry.
  7. * Patients of childbearing potential must use an effective form of contraceptive as per the protocol.
  1. * History of previous head and neck radiotherapy
  2. * Intent of treatment palliative
  3. * Women who are pregnant
  4. * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety of efficacy assessment of the investigational regimen should be included.
  5. * Psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol and/or follow-up procedures outlined in the protocol.

Contacts and Locations

Principal Investigator

Christina Henson, MD
PRINCIPAL_INVESTIGATOR
University of Oklahoma

Study Locations (Sites)

University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
United States

Collaborators and Investigators

Sponsor: University of Oklahoma

  • Christina Henson, MD, PRINCIPAL_INVESTIGATOR, University of Oklahoma

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2026-05
Study Completion Date2027-11

Study Record Updates

Study Start Date2026-05
Study Completion Date2027-11

Terms related to this study

Keywords Provided by Researchers

  • Imaging device

Additional Relevant MeSH Terms

  • Head and Neck Squamous Cell Carcinoma